RP-66055

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameRP-66055
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptors inhibitors
TargetsGlutamate receptors
Therapy Area/IndicationsEpilepsyNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsEpilepsyNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A